SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-17-067388
Filing Date
2017-11-09
Accepted
2017-11-09 16:16:54
Documents
2
Period of Report
2017-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a17-26328_18k.htm 8-K 26463
2 EX-99.1 a17-26328_1ex99d1.htm EX-99.1 74414
  Complete submission text file 0001104659-17-067388.txt   102070
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38129 | Film No.: 171191048
SIC: 2834 Pharmaceutical Preparations